Doucet M et al.Preclinical development of a vaccine against oligomeric alpha-synuclein based on virus-like particles.PLoS One 12:e0181844 (2017).
Karampetsou M et al.Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice.Sci Rep 7:16533 (2017).
Landeck N et al.A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein.Mol Neurodegener 11:61 (2016).
Mouse, Rat, Human
Price DL et al.Longitudinal live imaging of retinal a-synuclein::GFP deposits in a transgenic mouse model of Parkinson's Disease/Dementia with Lewy Bodies.Sci Rep 6:29523 (2016).
Ryan BJ et al.a-Synuclein and mitochondrial bioenergetics regulate tetrahydrobiopterin levels in a human dopaminergic model of Parkinson disease.Free Radic Biol Med 67C:58-68 (2013).
Giasson BI et al.A panel of epitope-specific antibodies detects protein domains distributed throughout human alpha-synuclein in Lewy bodies of Parkinson's disease.J Neurosci Res 59:528-33 (2000).